ECSP982766A - DERIVATIVES OF N- (CARBOMIMIDOFENOL) - FENILGLICINAMIDA - Google Patents

DERIVATIVES OF N- (CARBOMIMIDOFENOL) - FENILGLICINAMIDA

Info

Publication number
ECSP982766A
ECSP982766A ECSP982766A ECSP982766A EC SP982766 A ECSP982766 A EC SP982766A EC SP982766 A ECSP982766 A EC SP982766A EC SP982766 A ECSP982766 A EC SP982766A
Authority
EC
Ecuador
Prior art keywords
derivatives
fenilglicinamida
carbomimidofenol
carbamimidophenylamino
glycinamide
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Yu-Hua Ji
Katrin Grobke
Sabine Wallbaum
Lutz Weber
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982766 priority Critical patent/ECSP982766A/en
Publication of ECSP982766A publication Critical patent/ECSP982766A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Los nuevos derivados de N-(4-carbamimidofenilamino)fenil-glicinamida de la fórmula (gráfico), en donde E, G1, G2, Q, R y X1 a X4 son cada uno como se ha definido en la descripción, e hidratos o solvatos y sus sales fisiológicamente aceptables pueden utilizarse como inhibidores de la formación de los factores de coagulación Xa, IXa y trombina inducida por el factor VIIa y por el tejido, especificamente como medicamentos para el tratamiento y/o prevención de trombosis, aplopejia, infarto cardiaco, inflamación y arterioesclerosis o como agentes antitumorales.The new derivatives of N- (4-carbamimidophenylamino) phenyl-glycinamide of the formula (graph), wherein E, G1, G2, Q, R and X1 to X4 are each as defined in the description, and hydrates or Solvates and their physiologically acceptable salts can be used as inhibitors of factor VIIa and tissue-induced coagulation factors Xa, IXa and thrombin, specifically as medicinal products for the treatment and / or prevention of thrombosis, stroke, heart attack , inflammation and arteriosclerosis or as antitumor agents.

ECSP982766 1998-12-03 1998-12-03 DERIVATIVES OF N- (CARBOMIMIDOFENOL) - FENILGLICINAMIDA ECSP982766A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982766 ECSP982766A (en) 1998-12-03 1998-12-03 DERIVATIVES OF N- (CARBOMIMIDOFENOL) - FENILGLICINAMIDA

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982766 ECSP982766A (en) 1998-12-03 1998-12-03 DERIVATIVES OF N- (CARBOMIMIDOFENOL) - FENILGLICINAMIDA

Publications (1)

Publication Number Publication Date
ECSP982766A true ECSP982766A (en) 2000-08-18

Family

ID=42043685

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982766 ECSP982766A (en) 1998-12-03 1998-12-03 DERIVATIVES OF N- (CARBOMIMIDOFENOL) - FENILGLICINAMIDA

Country Status (1)

Country Link
EC (1) ECSP982766A (en)

Similar Documents

Publication Publication Date Title
MY133897A (en) N-(4-carb-amimidophenyl) glycineamide derivatives
NZ511927A (en) Phenylglycine derivatives
CY1107149T1 (en) New amidinobenzylamine derivatives and their use as thrombin inhibitors
ES2096673T3 (en) USE OF SULFONAMIDES AS MEDICINES AND NEW SULFONAMIDES.
BRPI0014076B8 (en) benzamides and related factor xa inhibitors
SE0101387D0 (en) Novel compounds
ES2421948T3 (en) Compounds and compositions for delivering active agents
ES2192213T3 (en) ARILALQUIL-DIAZINONAS AS PHOSPHODIESTERASE IV INHIBITORS.
PL375360A1 (en) Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
NO20002958D0 (en) Benzamidine derivatives as coagulation factor Xa inhibitors
DE60045508D1 (en) DALDA ANALOGS AND THEIR USE
DE60121461D1 (en) CONDENSED PYRIDOINDOL DERIVATIVES
ES2193055T3 (en) N- (2-HYDROXY-3- (1-PIPERIDINYL) PIRIDINE-1-OXIDE-3-CARBOXIMIDOYL CHLORIDE AND ITS USE IN THE TREATMENT OF INSULIN RESISTANCE.
CY1110130T1 (en) MORPHOLINE PRODUCTS FOR USE AS DOPAMINE AGONISTS IN THERAPEUTIC DISEASE Therapeutic Treatment I.A.
SE0101932D0 (en) Pharmaceutical combinations
PE20030061A1 (en) 1-BIARIL-1,8-NAPHTHYRIDIN-4-ONA AS PHOSPHODIESTERASE-4 INHIBITORS
SE9802208D0 (en) Novel compounds
AR002245A1 (en) ANTAGONISTS OF THE ADHESION RECEPTOR, PROCEDURE TO PREPARE THEM, PHARMACEUTICAL PREPARATIONS THAT CONTAIN THEM AND THE USE OF THE SAME TO PREPARE MEDICINES.
UY26895A1 (en) PIRAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS TO MODULATE AND / OR INHIBIT THE ACTIVITY OF ERAB / HADH2
BR9813719A (en) Therapeutic agents
UY29979A1 (en) SPIROCICLIC DERIVATIVES
UY27324A1 (en) NEW NAPSILATE SALTS I
AR019322A1 (en) SULFONYL DERIVATIVES REPLACED BY HETEROCICLO-ETANODIONANILINA REPLACED BY HETEROCICLO, PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND ITS USE FOR LAMANUFACTURE OF A MEDICINAL PRODUCT
UY26329A1 (en) VITRONECTIN RECEPTOR ANTAGONISTS
AR023452A1 (en) USE OF OSANETANT FOR PREPARATION OF USEFUL MEDICINES IN THE TREATMENT OF HUMOR DISORDERS